Literature DB >> 15963080

Most Helicobacter pylori strains of Kolkata in India are resistant to metronidazole but susceptible to other drugs commonly used for eradication and ulcer therapy.

S Datta1, S Chattopadhyay, R Patra, R De, T Ramamurthy, J Hembram, A Chowdhury, S K Bhattacharya, D E Berg, G B Nair, A K Mukhopadhyay.   

Abstract

BACKGROUND: Helicobacter pylori infection is very common in India, as in other developing countries, but few data exist on the susceptibility of H. pylori to antimicrobial agents commonly used for eradication here. AIM: To determine the antimicrobial susceptibility of H. pylori strains from Kolkata, in eastern India.
METHODS: A total of 67 H. pylori strains isolated from gastritis and peptic ulcer patients of Kolkata were examined in the study. Minimum inhibitory concentration to the antibiotics was determined by the agar dilution method.
RESULTS: Most of the strains (85%) were resistant to at least 8 microg/mL of metronidazole and 7.5% strains were resistant to tetracycline, which was high when compared with other reports in India. All Kolkata strains were highly sensitive to clarithromycin, furazolidone and amoxicillin.
CONCLUSIONS: Our results differed significantly from the few available reports on drug sensitivity profile of H. pylori from other parts of India, namely, Hyderabad, Mumbai and Lucknow. This finding supports the need for rigorous susceptibility testing as a guide to empirical treatment and more generally, to define the resistance patterns of H. pylori in particular geographical areas.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15963080     DOI: 10.1111/j.1365-2036.2005.02533.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  13 in total

1.  Antibiotic susceptibility of Helicobacter pylori clinical isolates: comparative evaluation of disk-diffusion and E-test methods.

Authors:  K K Mishra; S Srivastava; A Garg; A Ayyagari
Journal:  Curr Microbiol       Date:  2006-09-12       Impact factor: 2.188

2.  Antimicrobial susceptibility of Helicobacter pylori strains isolated from patients in Shiraz, Southern Iran.

Authors:  Shohreh Farshad; Abdolvahab Alborzi; Aziz Japoni; Reza Ranjbar; Kazem Hosseini Asl; Parisa Badiee; Maneli Amin Shahidi; Marziyeh Hosseini
Journal:  World J Gastroenterol       Date:  2010-12-07       Impact factor: 5.742

3.  Anti-Helicobacter pylori potential of artemisinin and its derivatives.

Authors:  Suchandra Goswami; Rajendra S Bhakuni; Annalakshmi Chinniah; Anirban Pal; Sudip K Kar; Pratap K Das
Journal:  Antimicrob Agents Chemother       Date:  2012-06-11       Impact factor: 5.191

4.  Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a randomized study.

Authors:  Mukesh Nasa; Ajay Choksey; Aniruddha Phadke; Prabha Sawant
Journal:  Indian J Gastroenterol       Date:  2013-10-26

5.  A Mouse Model of Helicobacter pylori Infection.

Authors:  Tanmoy Kumar Dey; Bipul Chandra Karmakar; Avijit Sarkar; Sangita Paul; Asish Kumar Mukhopadhyay
Journal:  Methods Mol Biol       Date:  2021

6.  Incidence of Helicobacter felis and the effect of coinfection with Helicobacter pylori on the gastric mucosa in the African population.

Authors:  E Lekunze Fritz; Tomas Slavik; Wayne Delport; Brenda Olivier; Schalk W van der Merwe
Journal:  J Clin Microbiol       Date:  2006-05       Impact factor: 5.948

7.  Antimicrobial activity of curcumin against Helicobacter pylori isolates from India and during infections in mice.

Authors:  Ronita De; Parag Kundu; Snehasikta Swarnakar; T Ramamurthy; Abhijit Chowdhury; G Balakrish Nair; Asish K Mukhopadhyay
Journal:  Antimicrob Agents Chemother       Date:  2009-02-09       Impact factor: 5.191

8.  Antimicrobial susceptibility and mutations involved in clarithromycin resistance in Helicobacter pylori isolates from patients in the western central region of Colombia.

Authors:  Adalucy Alvarez; José Ignacio Moncayo; Jorge Javier Santacruz; Mario Santacoloma; Luisa Fernanda Corredor; Elizabeth Reinosa
Journal:  Antimicrob Agents Chemother       Date:  2009-06-22       Impact factor: 5.191

9.  Efficacy and safety of sequential therapy versus standard triple therapy in Helicobacter pylori eradication in Kashmir India: a randomized comparative trial.

Authors:  Gul Javid; Showkat Ali Zargar; Khurshid Bhat; Bashir Ahmad Khan; Ghulam Nabi Yatoo; Ghulam Mohamad Gulzar; Altaf Hussain Shah; Jaswinder Singh Sodhi; Mushtaq Ahmad Khan; Abid Shoukat; Riyaz U Saif
Journal:  Indian J Gastroenterol       Date:  2013-03-21

10.  Management of Helicobacter pylori infection: The Bhubaneswar Consensus Report of the Indian Society of Gastroenterology.

Authors:  Shivaram Prasad Singh; Vineet Ahuja; Uday C Ghoshal; Govind Makharia; Usha Dutta; Showkat Ali Zargar; Jayanthi Venkataraman; Amit Kumar Dutta; Asish K Mukhopadhyay; Ayaskanta Singh; Babu Ram Thapa; Kim Vaiphei; Malathi Sathiyasekaran; Manoj K Sahu; Niranjan Rout; Philip Abraham; Prakash Chandra Dalai; Pravin Rathi; Saroj K Sinha; Shobna Bhatia; Susama Patra; Ujjala Ghoshal; Ujjal Poddar; Venigalla Pratap Mouli; Vikram Kate
Journal:  Indian J Gastroenterol       Date:  2021-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.